Summary & Overview
CPT 96573: Photodynamic Therapy with Topical Photosensitizer
CPT code 96573 covers photodynamic therapy in which a provider applies a photosensitizing drug to a lesion and exposes the area to a wavelength of light to destroy precancerous cells of the skin and adjacent mucosa. The code is reportable only once per day and applies to procedures performed by a physician or other qualified health care professional. As a targeted, localized therapy for superficial precancerous and early neoplastic lesions, the code has clinical relevance across dermatology and certain otolaryngology or oral mucosal practices.
Key payers in the national coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and site-of-service considerations, typical billing and reporting constraints, and where to look for payer-specific coverage and reimbursement policies. The publication also summarizes common modifiers and administrative details when available and notes when input data are incomplete.
This analysis is designed for national audiences seeking a concise reference on the service definition, typical care settings, and payer scope for CPT code 96573, supporting operational, coding, and policy decision-making.
Billing Code Overview
CPT code 96573 describes a physician or other qualified health care professional applying a photosensitizing drug to a lesion and exposing the treated area to a specific wavelength of light to destroy precancerous cells of skin and adjacent mucosa. The procedure is typically performed when targeted photodynamic therapy is indicated to treat superficial precancerous or early neoplastic lesions.
Service type: Photodynamic therapy (topical photosensitizer application with light activation)
Typical site of service: Outpatient dermatology clinic or ambulatory surgical center, depending on lesion location and required depth of light penetration.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of chronic sun exposure presents to a dermatology clinic with multiple actinic keratoses and a field of dysplastic, precancerous lesions on the dorsal hands and forearms. After evaluation by a board-certified dermatologist, the decision is made to perform photodynamic therapy to treat superficial precancerous lesions. On the day of service the patient is prepared in a dermatology procedure room: informed consent is confirmed, lesions are cleansed, a photosensitizing agent is applied to the target lesion(s), and the agent is allowed an incubation period. The provider then exposes the treated area to a specific wavelength light source for the prescribed time to activate the photosensitizer and induce selective cell destruction. Post-procedure wound care instructions are given and a follow-up visit is scheduled.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Office or other outpatient E/M — typically default | Use when reporting an unrelated E/M service on the same day as the procedure when applicable and documented. |
22 | Increased procedural services | Use when the work, time, or intensity substantially exceeds the typical for photodynamic therapy and documentation supports increased reimbursement. |